Interleukin-6 signaling and anti-interleukin-6 therapeutics in cardiovascular disease

PM Ridker, M Rane - Circulation research, 2021 - Am Heart Assoc
IL (interleukin)-6 is a pivotal cytokine of innate immunity, which enacts a broad set of
physiological functions traditionally associated with host defense, immune cell regulation …

Anemia in chronic kidney disease: from pathophysiology and current treatments, to future agents

J Portolés, L Martín, JJ Broseta, A Cases - Frontiers in Medicine, 2021 - frontiersin.org
Anemia is a common complication in chronic kidney disease (CKD), and is associated with a
reduced quality of life, and an increased morbidity and mortality. The mechanisms involved …

IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial

PM Ridker, M Devalaraja, FMM Baeres… - The Lancet, 2021 - thelancet.com
Background IL-6 has emerged as a pivotal factor in atherothrombosis. Yet, the safety and
efficacy of IL-6 inhibition among individuals at high atherosclerotic risk but without a …

Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty

L Ferrucci, E Fabbri - Nature Reviews Cardiology, 2018 - nature.com
Most older individuals develop inflammageing, a condition characterized by elevated levels
of blood inflammatory markers that carries high susceptibility to chronic morbidity, disability …

Osteocyte-related cytokines regulate osteoclast formation and bone resorption

H Kitaura, A Marahleh, F Ohori, T Noguchi… - International journal of …, 2020 - mdpi.com
The process of bone remodeling is the result of the regulated balance between bone cell
populations, namely bone-forming osteoblasts, bone-resorbing osteoclasts, and the …

Inflammation and sarcopenia: a focus on circulating inflammatory cytokines

L Pan, W Xie, X Fu, W Lu, H Jin, J Lai, A Zhang… - Experimental …, 2021 - Elsevier
Sarcopenia is an aged-related syndrome that is progressive and can be accelerated by
other concomitant disease states. Sarcopenia, characterized by loss of skeletal muscle …

Targeting innate immunity-driven inflammation in CKD and cardiovascular disease

T Speer, S Dimmeler, SJ Schunk, D Fliser… - Nature Reviews …, 2022 - nature.com
Mortality among patients with chronic kidney disease (CKD) is largely a consequence of
cardiovascular disease (CVD) and is a particular concern given the increasing prevalence of …

Inflammation‐related mechanisms in chronic kidney disease prediction, progression, and outcome

S Mihai, E Codrici, ID Popescu… - Journal of …, 2018 - Wiley Online Library
Persistent, low‐grade inflammation is now considered a hallmark feature of chronic kidney
disease (CKD), being involved in the development of all‐cause mortality of these patients …

[HTML][HTML] Chronic inflammation in chronic kidney disease progression: role of Nrf2

P Stenvinkel, GM Chertow, P Devarajan, A Levin… - Kidney international …, 2021 - Elsevier
Despite recent advances in the management of chronic kidney disease (CKD), morbidity
and mortality rates in these patients remain high. While pressure-mediated injury is a well …

Distinct longevity mechanisms across and within species and their association with aging

A Tyshkovskiy, S Ma, AV Shindyapina, S Tikhonov… - Cell, 2023 - cell.com
Lifespan varies within and across species, but the general principles of its control remain
unclear. Here, we conducted multi-tissue RNA-seq analyses across 41 mammalian species …